AstraZeneca

Related Articles

Antiplatelet Therapy

Low Clopidogrel Responsiveness Predicts Stent Thrombosis, Heart Attack
Tailored Therapy Using Clopidogrel is Superior to Prasugrel in Reducing High Platelet Reactivity
PLATO Sub-Analysis Suggests Age Has No Impact on Greater Reduction in Thrombotic Cardiovascular Events With Ticagrelor
New Data and Recent Advances in Antiplatelet Agents
Ticagrelor Added to American College of Chest Physicians’ Recommendations on Antithrombotic Therapy
Ticagrelor Receives Class I Recommendation in New U.S. Guidelines for PCI
FDA Clears Ticagrelor Blood-Thinning Drug Brilinta to Treat Acute Coronary Syndromes

Clinical Trial/Study

Low Clopidogrel Responsiveness Predicts Stent Thrombosis, Heart Attack
PLATO Sub-Analysis Suggests Age Has No Impact on Greater Reduction in Thrombotic Cardiovascular Events With Ticagrelor
New Study Suggests Potent Antiplatelet Drug Effective with Low-Dose Aspirin
New Data Show Rosuvastatin Significantly Reduces Major Cardiac Events
FDA Committee Looks Favorably on Giving Cholesterol Drug to Healthy People
New Drug Application Submitted for Anti-Platelet Agent
Tricagrelor Reduces Death, Heart Attacks Without Increased Bleeding Compared to Clopidogrel
CRESTOR Reduced Risk of Cardiovascular Events in Elderly in New Analysis of JUPITER Study
Head to Head Trial Shows Ticagrelor Reduced Cardiovascular Death, MI Over Clopidogrel

Pharmaceuticals

Low Clopidogrel Responsiveness Predicts Stent Thrombosis, Heart Attack
New Data and Recent Advances in Antiplatelet Agents
Ticagrelor Added to American College of Chest Physicians’ Recommendations on Antithrombotic Therapy
Ticagrelor Receives Class I Recommendation in New U.S. Guidelines for PCI
FDA Clears Ticagrelor Blood-Thinning Drug Brilinta to Treat Acute Coronary Syndromes
FDA Requests Further Analysis for Ticagrelor
New Data Show Rosuvastatin Significantly Reduces Major Cardiac Events
FDA Extends Review Timeline for Ticagrelor New Drug Application
Tricagrelor Recommended for Approval by FDA Committee
Court Denies Request for Generic Version of Crestor
Statin Gains New European Indication to Prevent Cardiovascular Events
Session Examines Anti-Platelet Therapies During ACC
Popular Statin Cleared to Help Reduce Stroke, Heart Attack, Revascularization
University of Virginia Collaborates to Develop New Cardio Drugs
FDA Committee Looks Favorably on Giving Cholesterol Drug to Healthy People
New Drug Application Submitted for Anti-Platelet Agent
FDA Clears CRESTOR for Pediatric Patients With Heterozygous Familial Hypercholesterolemia
Tricagrelor Reduces Death, Heart Attacks Without Increased Bleeding Compared to Clopidogrel
CRESTOR Reduced Risk of Cardiovascular Events in Elderly in New Analysis of JUPITER Study
Head to Head Trial Shows Ticagrelor Reduced Cardiovascular Death, MI Over Clopidogrel
Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL
Study Analysis Shows CRESTOR Reduces Risk of Blood Clots in Veins
Docs, Investors Await News on Plaque Drug

Cath Lab

Low Clopidogrel Responsiveness Predicts Stent Thrombosis, Heart Attack
PLATO Sub-Analysis Suggests Age Has No Impact on Greater Reduction in Thrombotic Cardiovascular Events With Ticagrelor
New Data and Recent Advances in Antiplatelet Agents
Ticagrelor Receives Class I Recommendation in New U.S. Guidelines for PCI
FDA Clears Ticagrelor Blood-Thinning Drug Brilinta to Treat Acute Coronary Syndromes
FDA Requests Further Analysis for Ticagrelor
FDA Extends Review Timeline for Ticagrelor New Drug Application
Tricagrelor Recommended for Approval by FDA Committee
Session Examines Anti-Platelet Therapies During ACC
Popular Statin Cleared to Help Reduce Stroke, Heart Attack, Revascularization
Tricagrelor Reduces Death, Heart Attacks Without Increased Bleeding Compared to Clopidogrel

Platelet Function Monitors

New Data and Recent Advances in Antiplatelet Agents

General Cardiology

Tricagrelor Recommended for Approval by FDA Committee
Popular Statin Cleared to Help Reduce Stroke, Heart Attack, Revascularization

Education/Training

Session Examines Anti-Platelet Therapies During ACC

Cardiology Related

Popular Statin Cleared to Help Reduce Stroke, Heart Attack, Revascularization